Alprazolam inclusion complexes and pharmaceutical compositions thereof
OwnerLawrence John Penklerinventor
Life of this patent
Estimating the term…
Abstract
Pharmaceutical composition for transmucosal delivery contains an inclusion complex of alprazolam and a water soluble unsubstituted or substituted beta- or gamama-cyclodextiin such as 2-hydroxypropyl beta-cyclodextfin, and a pharmaceutically acceptable carrier therefor. The pharmaceutical composition is of particular application in the treatment of Generalised Anxiety Disorder or for the management of panic disorders.
Claims18
A pharmaceutical composition for transmucosal delivery comprising an inclusion complex of (a) alprazolam and (b) a water soluble unsubstituted or substituted beta-or gamma-cyclodextrin, and a pharmaceutically acceptable carrier therefor.
An inclusion complex of alprazolam and a water soluble unsutstituted or substituted beta- or gamma-cyclodextrin.
The use of an inclusion complex of alprazolam and a water soluble unsubstituted or substituted beta- or gamma-cyclodextrin in the manufacture of a medicament for use in the treatment of generalised anxiety disorder or for the management of panic disorders.
A method of treating a patient suffering from generalised anxiety disorder or of management of a patient suffering from a panic disorder comprising transmucosal administration of an inclusion complex of alprazolam and a water soluble unsubstituted or substituted beta- or gamma-cyclodextrin.
Dependencies are inferred from the claim text.